THE DEAL, AT A GLANCE
From the announcementSeattle biotech InduPro
01Who is involvedBacked by The Column Group, Vida Ventures, MRL Ventures Fund, Emerson CollectiveFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedSeattle biotech InduPro raised $77M Series B, announced 2026-08-14From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersInduPro's $77M Series B positions the Seattle biotech to advance a cancer treatment pipeline built around proximity-guided therapeutics.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Seattle biotech InduPro · Financing Record
Explore source-linked visual explanations for Seattle biotech InduPro. Unsupported claims are withheld while source review continues.
Record 10258 · Recorded date: 2026-08-14
Explore company records →